LODINE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Lodine, and when can generic versions of Lodine launch?

Lodine is a drug marketed by Wyeth Pharms Inc and is included in two NDAs.

The generic ingredient in LODINE is etodolac. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the etodolac profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lodine

A generic version of LODINE was approved as etodolac by PANGEA on April 11^th, 1997.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LODINE?
What are the global sales for LODINE?
What is Average Wholesale Price for LODINE?

Summary for LODINE

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	118
Patent Applications:	4,499
DailyMed Link:	LODINE at DailyMed

Drug patent expirations by year for LODINE

US Patents and Regulatory Information for LODINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-002	Jan 31, 1991		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-002	Oct 25, 1996		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	TABLET;ORAL	018922-005	Jun 28, 1996		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-003	Jan 31, 1991		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	TABLET;ORAL	018922-004	Jul 29, 1993		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Wyeth Pharms Inc	LODINE XL	etodolac	TABLET, EXTENDED RELEASE;ORAL	020584-003	Jan 20, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LODINE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-003	Jan 31, 1991	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-002	Jan 31, 1991	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-003	Jan 31, 1991	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	CAPSULE;ORAL	018922-002	Jan 31, 1991	⤷ Sign Up	⤷ Sign Up
Wyeth Pharms Inc	LODINE	etodolac	TABLET;ORAL	018922-004	Jul 29, 1993	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LODINE

See the table below for patents covering LODINE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Finland	54125		⤷ Sign Up
France	2140154		⤷ Sign Up
Japan	S5638594		⤷ Sign Up
Germany	2226340		⤷ Sign Up
Netherlands	7207408		⤷ Sign Up
Sweden	387122	FORFARANDE FOR FRAMSTELLNING AV PYRANO(3,4-B)INDOL- ELLER TIOPYRANO(3,4-B)INDOLDERIVAT MED TERAPEUTISK VERKAN	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for LODINE

Make Better Decisions: Try a trial or see plans & pricing